Azetidine derivatives, their preparation and medicaments containing them
申请人:——
公开号:US20020035102A1
公开(公告)日:2002-03-21
The invention concerns compounds of formula (1) wherein: R represents a chain (A) or (B); R
1
is methyl or ethyl; R
2
is either an optionally substituted aromatic or an optionally substituted heteroaromatic ring; R
3
and R
4
, identical or different, are either an optionally substituted aromatic or an optionally substituted heteroaromatic ring; R′ represents a hydrogen atom or a —CO—alk radical, their optical isomers, their salts, their preparation and medicines containing them.
1
Acetindine derivatives, their preparation and medicaments containing them
申请人:——
公开号:US20030162808A1
公开(公告)日:2003-08-28
Disclosed are azetidine derivatives of formula:
1
their optical isomers, their salts, their preparation and medicaments containing them.
本发明涉及一种公开的式(1)的氮杂环丙烷衍生物,其光学异构体,其盐,其制备方法以及含有它们的药物。
AZETIDINE DERIVATIVES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM
申请人:Achard Daniel
公开号:US20060270649A1
公开(公告)日:2006-11-30
Disclosed are azetidine derivatives of formula:
their optical isomers, their salts, their preparation and medicaments containing them.
本发明涉及一种式子为的氮杂环丙烷衍生物,包括其光学异构体、其盐、其制备方法以及含有它们的药物。
Galactoside inhibitor of galectins
申请人:Galecto Biotech AB
公开号:US11377464B2
公开(公告)日:2022-07-05
An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.